Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

153.89 +1.51 (+0.99%)
Official Closing Price Updated: 4:10 PM EDT, Mar 20, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,124,757
Open 152.47
Bid (Size) 153.60 (5)
Ask (Size) 153.91 (3)
Prev. Close 152.38
Today's Range 152.38 - 154.07
52wk Range 150.71 - 186.69
Shares Outstanding 2,628,679,824
Dividend Yield 2.63%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
3 Dow Stocks Near 52-Week Lows That Look Like Bargains Now
These businesses are performing much better than their stock prices would suggest. 
Via The Motley Fool
Top 8 Stocks To Profit From Rising Interest Rates
The US Federal Reserve raises interest rates when the market is growing too fast, which is what has been happening over the past year. Here are some stocks to help you answer the question of how to... 
Via Talk Markets

Performance

YTD
-13.64%
-13.64%
1 Month
-4.05%
-4.05%
3 Month
-12.30%
-12.30%
6 Month
-7.45%
-7.45%
1 Year
-12.48%
-12.48%

More News

Read More
3 Retirement Investing Moves to Help Get You Back on Track
Via The Motley Fool
Ready to Buy the Dip? Johnson & Johnson Stock Is a Smart Buy
Via The Motley Fool
5 Stocks You Can Confidently Invest $500 in Right Now
Via The Motley Fool
Looking Into Johnson & Johnson's Recent Short Interest
Via Benzinga
Johnson & Johnson Unusual Options Activity
Via Benzinga
Protagonist Therapeutics Touts Positive Data From Bone Marrow Disorder Study
Via Benzinga
Looking At Johnson & Johnson's Recent Unusual Options Activity
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Medicare Negotiation Hammers Biotech Stocks Regeneron, Halozyme
Via Investor's Business Daily
Johnson & Johnson to Host Investor Conference Call on First-Quarter Results
From Johnson & Johnson
Via Business Wire
Johnson & Johnson's Experimental Dengue Pill Shows Efficacy In Animal Studies
Via Benzinga
7 Blue-Chip Stocks to Buy and Hold for Decades
Via InvestorPlace
Janssen Announces Novel Dengue Antiviral Demonstrates Efficacy in Pre-Clinical Data Published in Nature
From Johnson & Johnson
Via Business Wire
3 Blue-Chip Dividend Stocks to Buy on the Dip Now
Via InvestorPlace
Healthcare Stocks With at Least 30 Years of Dividend Increases
Via MarketBeat
5 Forever Dividend Stocks
Via The Motley Fool
Best-Selling Drugs by Bristol Myers, Pfizer, AbbVie Likely Candidates For US Price Negotiation
Via Benzinga
Jeff Bezos, George Soros, Mark Cuban, and Ray Dalio All Have One Thing in Common: They're Making a Big Bet on This Industry
Via Benzinga
DSS Inc (NYSE American: DSS) Has Three IPO Spinoffs Planned For 2023 — Is It On Your Watchlist?
Via Benzinga
3 Reliable Dividend Stocks to Buy and Hold for Decades of Passive Income
Via The Motley Fool
These 3 Dow Stocks Are the Cheapest They've Been in Over a Decade
Via The Motley Fool
7 Blue-Chip Stocks to Buy in March
Via InvestorPlace
These 7 Dividend Stocks Pay $96 Billion a Year, Combined, to Their Shareholders
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.